
Olmipro AH 40mg/5mg/12.5mg Tablet
Marketer
Mandevis Pharma
Salt Composition
Olmesartan Medoxomil (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Olmipro AH 40mg/5mg/12.5mg Tablet
Amlodipine/Hydrochlorothiazide/Olmesartan 40mg/5mg/12.5mg tablets are a triple-drug formulation for managing hypertension when monotherapy proves insufficient. This combination lowers elevated blood pressure, significantly decreasing the risk of stroke and myocardial infarction. Administer this medication with or without food, at the same time daily, as directed by your physician. Continue treatment as prescribed; discontinuation may increase cardiovascular event risk. This medication includes a diuretic, increasing urination, so avoid dosing within four hours of bedtime. Consistent use is crucial for optimal therapeutic benefit, even during asymptomatic periods. Common side effects may include edema, cephalalgia, vertigo, fatigue, and altered taste perception. Report persistent, worsening, or bothersome side effects to your doctor. Adequate hydration is advised to mitigate potential side effects like myalgia, xerostomia, and polydipsia. Prior to commencement, inform your physician of any renal or hepatic impairment, pregnancy, breastfeeding, or concurrent medications, particularly those for hypertension or cardiac conditions. Regular monitoring of blood pressure, renal function, electrolyte levels, and blood glucose is necessary to ensure treatment efficacy and safety.
Uses of Olmipro AH 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Olmipro AH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the Olmipro AH 40mg/5mg/12.5mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be independent thereof, though consistent timing is recommended.
Common Side effects of Olmipro AH 40mg/5mg/12.5mg Tablet:
- Headache
- Dizziness
- Nausea
- Upper respiratory tract infection
- Fatigue
- Urinary tract infection
- Diarrhea
- Joint swelling
- Peripheral edema
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Muscle spasm
- Hypotension (low blood pressure)
- Increased creatinine level in blood
- Increased blood urea
- Increased uric acid level in blood
How to use Olmipro AH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olmipro AH 40mg/5mg/12.5mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Olmipro AH 40mg/5mg/12.5mg Tablet works:
Olmipro AH 40mg/5mg/12.5mg tablets contain olmesartan medoxomil, amlodipine, and hydrochlorothiazide, acting synergistically to manage hypertension. Olmesartan medoxomil, an angiotensin II receptor antagonist (ARB), and amlodipine, a calcium channel blocker (CCB), both promote vasodilation, reducing blood pressure. Hydrochlorothiazide, a diuretic, facilitates diuresis, eliminating excess fluid and electrolytes, and contributes to long-term vasodilation and improved circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Olmipro AH 40mg/5mg/12.5mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Olmipro AH 40mg/5mg/12.5mg tablets during pregnancy is contraindicated due to demonstrable risk to the fetus. In exceptional, life-threatening circumstances, a physician may prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Nursing mothers should likely avoid Olmipro AH 40mg/5mg/12.5mg Tablets. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Olmipro AH 40mg/5mg/12.5mg Tablet side effects. These side effects can include dizziness, headaches, nausea, or fatigue, potentially impacting concentration and safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Olmipro AH 40mg/5mg/12.5mg tablets, as dose modification may be necessary. A physician's consultation is advised. Olmipro AH 40mg/5mg/12.5mg tablets are generally unsuitable for individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Olmipro AH 40mg/5mg/12.5mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Olmipro AH 40mg/5mg/12.5mg Tablet :
Should you forget to take your Olmipro AH 40mg/5mg/12.5mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Olmipro AH 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |
